文件向在2019年asco会上发表演讲.pdfVIP

  • 0
  • 0
  • 约2.79千字
  • 约 21页
  • 2023-12-10 发布于北京
  • 举报

Riskofsubsequentcancerdiagnosisinpatientstreatedwith3Dconformal,intensitymodulated,orprotonbeamradiationtherapy

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Radiationandsecondcancerrisk

PresentedByMichaelXiangat2019ASCOAnnualMeeting

ComparisonsamongmodernRTmodalities

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Aim,methodology,anddatasource

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Methods:Cohortidentification(patientselection)

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Methods:Cohortidentification(tumortypeselection)

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Methods:Determinationofsecondcancer

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Methods:Determinationofsecondcancer

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Methods:Statisticalyses

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Methods:18variablesusedforadjustment

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Results:Cohortdescription

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Results:TumortypedistributionbyRTmodality

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Results:Absolutecrudeidenceofsecondcancer

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Results:IMRThassimilarsecondcancersas3DCRT

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Results:PBRTsignificantlylesssecondcancervsIMRT

PresentedByMichaelXiangat2019ASCOAnnualMeeting

Results:BenefitfavoringPBRTseenacrossal

文档评论(0)

1亿VIP精品文档

相关文档